Simple Summary Benign and intermediate bone tumours are often treated by intralesional
curettage together with local adjuvants in order to the reduce risk of local relapse. However …

Simple Summary Giant cell tumours are benign but locally aggressive and can potentially
metastasise to the lungs. Reducing the risk of local recurrence while maintaining limb …

Background In recent years, researchers have proposed a number of adjuvant methods for
extended curettage of giant cell tumors of the bone. However, various schemes have …

The effect of adjuvant cryotherapy added to well-performed high-speed burr curettage on the
long-term surgical outcomes of chondroblastoma cases - PMC Back to Top Skip to main content …

Aim As a locally destructive intermediate bone tumor with low incidence, high recurrence
rate, and difficulty in reconstruction, giant cell tumor of bone (GCTB) in the proximal femur …

Abstract Background In Japan, there are currently no general guidelines for the treatment of
primary malignant bone tumors. Therefore, the Japanese Orthopaedic Association …

Freezing nitrogen ethanol composite (FNEC) showed effective cryoablative ability for bone
tumor ex vivo and in vivo comparable to liquid nitrogen (LN). We therefore wished to …

The expression of matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix
metalloproteinase-3 (TIMP-3) in giant-cell tumor of bone (GCT), and the correlation of their …

El tumor de células gigantes (TCG) tiene una variedad muy versátil, desde la presentación
clínica en género y grupo etario hasta su grado de malignidad, llegando a ser mortal. Es …

The giant cell tumor (GCT) has a very versatile variety from the clinical presentation in
gender and age group to its degree of malignancy, becoming fatal; radiographic …